Venture Capital News: SafeRide Health Announces Series C Round
2023-10-05
SAN ANTONIO, CA, SafeRide Health announced today Series C funding to further scale its non-emergency medical transportation (NEMT) technology and services.
SafeRide Health- the leading technology-first platform connecting patients of the nation's largest Medicaid, Medicare Advantage, and provider programs to life sustaining care- announced today Series C funding to further scale its non-emergency medical transportation (NEMT) technology and services, led by Sands Capital.
Additional investors include healthcare leaders like Healthworx, the investment and innovation arm of CareFirst BlueCross BlueShield (CareFirst), and SCAN Group, a diversified healthcare company tackling some of the biggest healthcare challenges facing older adults today. They join other industry leaders and early investors in SafeRide Health, including Transform Capital, Seminal Capital (SEMCAP), Hill City Capital, Fry's Path Capital, Primetime Partners, Fresenius Medical Ventures, Bonfire Ventures, and Meridian Street Capital. Silicon Valley Bank, a division of First Citizens Bank, is expanding their existing credit-relationship alongside this equity raise.
SafeRide Health is a technology and services company dedicated to reducing barriers to care by improving the delivery of non-emergency medical transportation (NEMT) to people nationwide. SafeRide Health leverages proprietary technology and a nationwide network of vetted transportation providers to elevate human dimensions of care and close the gap between need and access for the nation's most vulnerable populations. SafeRide's scalable and intuitive platform gives payers and health systems a more intelligent way to deliver cost-effective, on-demand transportation that connects health plan members to critical healthcare services. SafeRide serves the country's largest Medicare Advantage, Medicaid, and provider programs.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors